title: JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
abstract: We investigated the effects of JBP485 (an anti-inflammatory dipeptide and a substrate of OAT) on regulation of the expression and function of renal Oat1 and Oat3, which can accelerate the excretion of accumulated uremic toxins (e.g. indoxyl sulfate) in the kidney to improve gentamicin-induced ARF in rats. JBP485 caused a significant decrease in the accumulation of endogenous substances (creatinine, blood urea nitrogen and indoxyl sulfate) in vivo, an increase in the excretion of exogenous compounds (lisinopril and inulin) into urine, and up-regulation of the expressions of renal Oat1 and Oat3 in the kidney tissues and slices via substrate induction. To determine the effect of JBP485 on the accelerated excretion of uremic toxins mediated by Oat1 and Oat3, the mRNA and protein expression levels of renal basolateral Oats were assessed by quantitative real-time PCR, western blot, immunohistochemical analysis and an immunofluorescence method. Gentamicin down-regulated the expression of Oats mRNA and protein in rat kidney, and these effects were reversed after administration of JBP485. In addition, JBP485 caused a significant decrease in MPO and MDA levels in the kidney, and improved the pathological condition of rat kidney. These results indicated that JBP485 improved acute renal failure by increasing the expression and function of Oat1 and Oat3, and by decreasing overoxidation of the kidney in gentamicin-induced ARF rats.
authors.affiliation: Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China.
authors.forename: Xinjin
authors.initials: X
authors.lastname: Guo
authors.forename: Qiang
authors.initials: Q
authors.lastname: Meng
authors.forename: Qi
authors.initials: Q
authors.lastname: Liu
authors.forename: Changyuan
authors.initials: C
authors.lastname: Wang
authors.forename: Huijun
authors.initials: H
authors.lastname: Sun
authors.forename: Jinyong
authors.initials: J
authors.lastname: Peng
authors.forename: Xiaochi
authors.initials: X
authors.lastname: Ma
authors.forename: Taiichi
authors.initials: T
authors.lastname: Kaku
authors.forename: Kexin
authors.initials: K
authors.lastname: Liu
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000188:drug therapy*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000652:urine; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D019540:Area Under Curve; D015153:Blotting, Western; D005455:Fluorescent Antibody Technique; D005839:Gentamicins; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007672:Kidney Cortex / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D017706:Lisinopril / Q000652:urine; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D013058:Mass Spectrometry; D027362:Organic Anion Transport Protein 1 / Q000096:biosynthesis / Q000378:metabolism*; D029362:Organic Anion Transporters, Sodium-Independent / Q000096:biosynthesis / Q000378:metabolism*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D009195:Peroxidase / Q000378:metabolism; D011500:Protein Synthesis Inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D005839:Gentamicins; C412308:JBP 485; D027362:Organic Anion Transport Protein 1; D029362:Organic Anion Transporters, Sodium-Independent; D010456:Peptides, Cyclic; D011500:Protein Synthesis Inhibitors; C421043:Slc22a6 protein, rat; C114338:organic anion transport protein 3; D008315:Malondialdehyde; D017706:Lisinopril; D009195:Peroxidase
keywords: ARF; Acute renal failure; BCA; BUN; CL(R); CL(TS); ECL; GFR; Gentamicin; JBP485; MDA; MPO; OAT; Organic anion transporters; PBS; Renal function; TBARS; Uremic toxins; acute renal failure; bicinchoninic acid; blood urea nitrogen; electrochemiluminescence; glomerular filtration rate; malondialdehyde; myeloperoxidase; organic anion transporter; phosphate buffered saline; renal clearance; thiobarbituric acid reactive substances; tubular secretory clearance